迪斯克医疗

US · IRON #2647 按市值排名上市于 1970

56.84 +0.19 +0.34%

实时 - 追踪5344个代码 - 心跳于572秒前 · 2026-10-16 20:01

✦ 量化股权信号计算方式说明

减持

最近一期（2026/Q3）披露持股的机构数量减少了1家。
机构持股总比例下降了0.4个百分点。

机构持股

机构持股比例: 121.04% -0.43pp
机构数量: 269 -1
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund60.80%

VC/PE Fund30.09%

Hedge Fund24.96%

Private Company3.04%

Public Company1.40%

Individual/Insider0.57%

Government Pension Fund0.33%

Sovereign Wealth Fund0.28%

Insurance Company0.15%

主要股东截至 2026-06-30

FMR 12.75% · 4.89M 股

Access Industries, Inc. 7.33% · 2.81M 股

BlackRock 6.43% · 2.47M 股

RA Capital Management, L.P. 6.38% · 2.45M 股

T. Rowe Price Group, Inc. 4.88% · 1.88M 股

J.P. Morgan Asset Management, Inc. 4.78% · 1.84M 股

Wellington Management Group 4.54% · 1.74M 股

State Street Global Advisors 4.29% · 1.65M 股

Vanguard Capital Management, LLC 4.15% · 1.59M 股

Vestal Point Capital, LP 4.04% · 1.55M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 22次买入 · 28次卖出

姓名	职务	持股比例
John Quisel	CEO, President, Secretary & Director	0.30%
William Savage	Chief Medical Officer	0.09%
Pamela Stephenson	Chief Commercial Officer	0.05%
Rahul Khara	General Counsel, Compliance Officer & Secretary	0.05%
Donald Nicholson	Independent Executive Chairman	0.04%
Jonathan Yu	Chief Business Officer	0.03%
Joanne Bryce	Chief Financial Officer	0.02%
Atlas Venture Advisors, Inc.	--	--
OrbiMed Advisors LLC	--	--
Access Industries, Inc.	--	--

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-14	John Quisel	CEO, President, Secretary & Director	Derivative Exercise and Retained	+36,000	$1.01
2026-09-10	Kevin Bitterman	Independent Director	Derivative Exercise and Sale	-27,136	$38.85–70.11
2026-09-03	Atlas Venture Advisors, Inc.	--	Automatic Disposition	-1,689	$79.96
2026-09-02	Atlas Venture Advisors, Inc.	--	Automatic Disposition	-54,496	$79.95–80.98
2026-08-24	Jonathan Yu	Chief Business Officer	Derivative Exercise and Sale	-9,096	$13.50–83.12
2026-08-16	John Quisel	CEO, President, Secretary & Director	Derivative Exercise and Sale	-33,000	$13.50–79.84
2026-08-11	Jonathan Yu	Chief Business Officer	Derivative Exercise and Sale	-804	$13.50–82.64
2026-08-05	Rahul Khara	General Counsel, Compliance Officer & Secretary	Derivative Exercise and Sale	-5,000	$14.69–80.00
2026-07-12	John Quisel	CEO, President, Secretary & Director	Derivative Exercise and Sale	-33,000	$9.86–76.05
2026-07-06	Jonathan Yu	Chief Business Officer	Derivative Exercise and Sale	-100	$13.50–82.50
2026-06-28	Rahul Khara	General Counsel, Compliance Officer & Secretary	Derivative Exercise and Sale	-2,500	$14.69–75.00
2026-06-25	Jonathan Yu	Chief Business Officer	Derivative Exercise and Sale	-300	$13.50–72.50
2026-06-21	Jonathan Yu	Chief Business Officer	Derivative Exercise and Sale	-9,700	$13.50–72.66
2026-06-17	Georges Gemayel	Director	Other Derivative Acquisition	+6,212	$70.79
2026-06-17	Kevin Bitterman	Independent Director	Other Derivative Acquisition	+6,212	$70.79
2026-06-17	Liam Ratcliffe	Independent Director	Other Derivative Acquisition	+6,212	$70.79
2026-06-17	John Quisel	CEO, President, Secretary & Director	Derivative Exercise and Sale	-34,000	$9.86–71.61
2026-06-17	Mark Chin	Independent Director	Other Derivative Acquisition	+6,212	$70.79
2026-06-17	Donald Nicholson	Independent Executive Chairman	Other Derivative Acquisition	+6,212	$70.79
2026-06-17	William White	Independent Director	Other Derivative Acquisition	+6,212	$70.79

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:01:07 · 仅供参考，不构成投资建议，也未考虑您的具体情况。